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R adiofiequency ablation of atrioventricular (AV) nodal reentrant tachycardia has been shown to be an effec- 
tive and safe treatment and to have a significant cost ad- 
vantage over other forms of therapy.* In studies report- 
ed to date, patients were hospitalized for 2 to 10 days 
after slow pathway ablation to monitor for possible com- 
plications or a recurrence of the tachycardia.*s3 A previ- 
ous study reported that radiofrequency ablation of acces- 
sory pathways can be performed safely on an outpatient 
basis: but no prior studies evaluated the safety of outpa- 
tient radiofrequency ablation of the slow pathway in pa- 
tients with AV nodal reentrant tachycardia. Therefore, 
the purpose of this study was to evaluate the safety and 
cost of performing radiofrequency catheter ablation of 
the slow AV nodal pathway on an outpatient basis. 
The study population comprised 139 consecutive pa- 
tients (38 men and 101 women, mean age 4.5 f 16 
years) who underwent radiofrequency ablation of the 
slow pathway for treatment of AV nodal reentrant 
tachycardia at the University of Michigan Medical Cen- 
ter between August 30, 1991 and December 2, 1992. 
One hundred thirty-one patients did not have structural 
heart disease; 4 had coronary artery disease, and 1 
each had mitral valve prolapse, mitral regurgitation or 
a dilated cardiomyopathy. 
The procedure was perJormed with patients in the 
fasting state after discontinuation of all antiarrhythmic 
medications for 224 hours and after informed written 
consent was obtained. Three 7 or 8Fr sheaths were 
positioned in the right femoral vein, and 3 quadripolar 
electrode catheters were positioned in the high right 
atrium, His bundle position and right ventricle. All pa- 
tients received a 3,000 IU bolus of heparin intraven- 
ously after initial placement of catheters. Intravenous 
midazolam was used for sedation. An initial diagnostic 
electrophysiologic test was pet$ormed to determine the 
tachycardia mechanism, and the anterograde and ret- 
rograde conduction properties and refractory periods of 
the fast and slow AV nodal pathways. 
The ablation catheter was a ‘7Fr bipolar or quadripo- 
lar electrode catheter with a 4 mm distal electrode and 
2 to 5 mm interelectrode spacing (EP Technologies, 
Inc., Mountain View, California, or MansJield-Scientif- 
ic, Boston). Radiofiequency energy was delivered as an 
unmodulated sine wave at 500 KHz (EP Technologies) 
between the distal electrode of the ablation catheter and 
a large skin electrode on the back, and was applied at 
power outputs of 30 to 35 W for 30 seconds. The 
application was terminated immediately in the event of 
coagulum formation, AV block or the occurrence of ven- 
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triculoatrial block during junctional ectopy. Target sites 
were selected by mapping along the posteromedial tri- 
cuspid annulus near the coronary sinus ostium and 
searching for a multicomponent atria1 electrogram or 
evidence of a possible slow pathway potential and an 
atrial:ventricular electrogram ratio ~0.5. After success- 
ful ablation, atria1 and ventricular stimulation was re- 
peated before and during the infusion of isoproterenol at 
a rate of 2 to 4 pgimin. Patients were observed in the 
electrophysiology laboratory for 30 minutes to rule out 
an acute recurrence of AV nodal reentrant tachycardia. 
Catheters and sheaths were removed at completion 
of the procedure, and manual compression was applied 
until complete hemostasis was achieved. If the observa- 
tion period could be completed by 7 P.M., patients were 
observed for 3 hours in an outpatient recovery unit; other- 
wise, they were admitted to the hospital overnight. 
Patients were scheduled for a follow-up visit 2 to 4 
weeks after the procedure and were instructed to contact 
an investigator or their referring physician cf tachycardia 
symptoms recurred. A follow-up electrophysiologic test 3 
months after the ablation procedure was recommended in 
patients who had had infrequent episodes of paroxysmal 
supraventricular tachycardia before the ablation procedure. 
Hospital billing records were reviewed to determine the 
hospital and professional charges in a subgroup of 40 con- 
secutive patients. Hospital charges included room and 
board, electrophysiology laboratory, recovery room and 
laboratory tests. Professional charges included physician 
fees for the catheter ablation procedure, and those relat- 
ed to patient care. 
Of 139 patients who underwent radiofrequency abla- 
tion of the slow AV nodal pathway, 120 qualtj?ed for early 
discharge on either the day of the procedure (n = 90) or 
the next morning (n = 30), with successful ablation in 119 
of 120. 
The reasons for continued hospitalization in 19 patients 
were the occurrence of a complication in 2, ablation of the 
fast AV nodal pathway in 6, a clinical indication for hos- 
pitalization unrelated to AV nodal reentrant tachycardia in 
4, and inpatient status at the time of the ablation proce- 
dure in 7. The 2 complications consisted of complete AV 
block that resolved within 24 hours in 1 patient and per- 
sisted in the other, necessitating implantation of a perma- 
nent pacemaker 
No complications related to the procedure were ob- 
served or reported when patients were observed 2 to 4 
weeks later. One hundred nineteen patients had no recur- 
rence of symptomatic tachycardia during 7 f 3 months of 
follow-up. One patient had a recurrence of tachycardia 3 
weeks after the procedure, necessitating repeat slow path- 
way ablation. Five of 82 patients who underwent a follow- 
up electrophysiologic test 3 months after the ablation pro- 
cedure were found to have inducible AV nodal reentrant 
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tachycardia; repeat radiofrequency ablation of the slow 
pathway was successful in each of these patients. No pa- 
tient was found to have AV block or prolongation of the 
AH interval at the time of the follow-up electrophysiology 
test. 
In 40 consecutive patients selected for the cost analy- 
sis, there were 27 outpatients and 13 admitted for an over- 
night hospital stay. The mean total charge for all 40 pa- 
tients was $10,547 + 1,062, consisting of $6,267 I!I 481 in 
professional fees, and $4,327 + 867 in hospital charges. 
The mean total charge for patients treated as outpatients 
was $10,192 f 846, consisting of $6,164 f 463 in pro- 
fessional fees, and $4,028 f 710 in hospital charges. The 
mean total charge for patients who had an overnight ad- 
mission was $11,240 + 763, consisting of $6,407 f 485 
in professional fees, and $4,833 f 946 in hospital charges. 
This study shows that it is safe to perform radiofre- 
quency ablation of the slow pathway in low-risk patients 
with AV nodal re-entrant tachycardia on an outpatient 
basis and that this may help in reducing the total cost 
of the procedure. Eighty-six percent of patients with AV 
nodal reentrant tachycardia who underwent radiofre- 
quency ablation of the slow pathway were thought to be 
appropriate candidates for early discharge and had no 
evidence of a complication during or within 3 hours 
after the procedure. No complication became apparent 
after discharge of these patients. The absence of any de- 
layed complications indicates that it is safe to discharge 
the patient if no complications are apparent by 3 hours 
after the procedure. 
The major concerns related to outpatient radiofre- 
quency ablation procedures include possible complica- 
tions of vascular access, AV block, pneumothorax and 
cardiac perforation. Because slow pathway ablation does 
not need arterial cannulation, the vascular complication 
rate would be expected to be low. Accordingly, in this 
study, there were no vascular complications related to 
vascular access. 
Because delayed AV block has occurred after ablation 
of the fast pathway, patients in this study who underwent 
fast pathway ablation did not qualify for outpatient man- 
agement. However, no cases of delayed AV block have 
been reported after slow pathway ablation, and this com- 
plication was not observed in the present study. 
In this study, only the right femoral vein was used for 
the placement of catheters, thereby avoiding the pos- 
sibility of a pneumothorax associated with subclavian or 
internal jugular vein cannulation. In patients who under- 
go cannulation of a subclavian or internal jugular vein, 
a chest roentgenogram to rule out a pneumothorax would 
be advisable before discharge from the hospital. In re- 
gard to cardiac perforation and the delayed onset of car- 
diac tamponade, this complication did not occur in the 
patients in this study or in other reports on outpatient 
electrophysiologic testing or radiofrequency ablation.5 
In a previous study, Kalbfleisch et al’ showed a sub- 
stantial cost advantage of radiofrequency ablation of the 
fast pathway in patients with AV nodal reentrant tachy- 
cardia compared with other forms of therapy. The pa- 
tients in that study had a mean hospital stay of 3.0 + 1.5 
days, and the total charges were $15,893 _+ 3,338. In the 
present study, the mean total charges were reduced to 
$10,192 f 846 for patients undergoing slow pathway ab- 
lation on an outpatient basis, representing a savings of 
36%. Therefore, the results of this study show that a 
substantial cost savings can be achieved when radiofre- 
quency ablation of the slow pathway is performed on an 
outpatient basis and that safety is not compromised 
when early discharge is limited to patients who are ap- 
propriate candidates for outpatient therapy. 
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Abnormal Hemodynamic Response to Valsalva Maneuver in Mitral 
Stenosis 
Liang-Miin Tsai, MD, and Jyh-Hong Chen, MD, PhD 
A cute hemodynamic response to the Valsalva maneu- ver has long been used as a means of assessing the 
circulatory changes in various cardiovascular dis- 
eases.lg An abnormal Valsalva response regarding 
blood pressure and heart rate changes has been report- 
ed in patients with mitral stenosis (MS).4-6 However, the 
central blood flow changes were not determined previ- 
ously, and hence the potential effects of cardiac stroke 
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output during this maneuver are poorly understood. Re- 
cently, Doppler echocardiography proved to be a useful 
noninvasive method to evaluate left ventricular stroke 
output.7-9 The purpose of the present study was to eval- 
uate the effect of the Valsalva maneuver on aortic blood 
flow profiles in patients with MS using the Doppler 
echocardiographic technique, and to better understand 
the extent and mechanism of abnormal hemodynamic 
response to this maneuver in MS based on the beat-to- 
beat estimation. 
Ten patients (5 men and 5 women; age range 25 to 
43 years, mean 37) with rheumatic MS as documented 
by physical examination ana’ echocardiography were 
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